<code id='4A239251AC'></code><style id='4A239251AC'></style>
      • <acronym id='4A239251AC'></acronym>
      <center id='4A239251AC'><center id='4A239251AC'><tfoot id='4A239251AC'></tfoot></center><abbr id='4A239251AC'><dir id='4A239251AC'><tfoot id='4A239251AC'></tfoot><noframes id='4A239251AC'>
      • <optgroup id='4A239251AC'><strike id='4A239251AC'><sup id='4A239251AC'></sup></strike><code id='4A239251AC'></code></optgroup>
        5. <b id='4A239251AC'><label id='4A239251AC'><select id='4A239251AC'><dt id='4A239251AC'><span id='4A239251AC'></span></dt></select></label></b><u id='4A239251AC'></u>
          <i id='4A239251AC'><strike id='4A239251AC'><tt id='4A239251AC'><pre id='4A239251AC'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / comprehensive      
           
     
           
      
          comprehensive 
           
      
           
      
           
       2025-10-02 12:04:01 
   
      
           
      
           
                        
          comprehensive  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：2731
                                  
                                    
          
                                   
          Adobe
          LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.
          The deal includes up to another $400 million in payments if certain milestones are met.
          advertisement
          Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          AltruBio raises $225 million to develop ulcerative colitis drug
                                
                            
          Next article：  
                                      
                                          Sports medicine is finally prioritizing gender equality
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles